{"disease":{"id":"disease-free-survival-rate","name":"disease free survival rate"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03900871","title":"Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal Carcinoma","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Hebei Medical University Fourth Hospital","has_results":false},{"nct_id":"NCT04782765","title":"Phase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":59,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}